Victory Capital Management
TECX

Victory Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Victory Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,122
Closed -$973K – 2863
2021
Q2 		$973K Sell
9,122
-1,734
-16% -$206K ﹤0.01% 1906
2021
Q1 		$1.65M Buy
10,856
+2,643
+32% +$430K ﹤0.01% 1701
2020
Q4 		$1.37M Sell
8,213
-1,489
-15% -$265K ﹤0.01% 1637
2020
Q3 		$1.52M Sell
9,702
-3,257
-25% -$656K ﹤0.01% 1531
2020
Q2 		$2.71M Sell
12,959
-59,513
-82% -$12.3M ﹤0.01% 1339
2020
Q1 		$13.5M Buy
72,472
+37,676
+108% +$8.87M 0.01% 1005
2019
Q4 		$8.4M Sell
34,796
-5,240
-13% -$1.01M 0.01% 1058
2019
Q3 		$6.78M Buy
40,036
+30,613
+325% +$6.93M 0.01% 1094
2019
Q2 		$1.84M Sell
9,423
-1,974
-17% -$426K ﹤0.01% 1160
2019
Q1 		$3.02M Buy
11,397
+11,155
+4,610% +$2.04M 0.01% 984
2018
Q4 		$48K Sell
242
-46
-16% -$14K ﹤0.01% 1696
2018
Q3 		$179K Buy
288
+38
+15% +$16.8K ﹤0.01% 1606
2018
Q2 		$86K Buy
+250
New +$90.2K ﹤0.01% 1718

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Victory Capital Management's TECX Position: Q3 2021 in Review

Victory Capital Management sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 9,122 shares — an estimated $973K sold.

Victory Capital Management first reported a position in TECX in Q2 2018 and held it in 13 quarters. The position peaked at $13.5M in Q1 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2021.

  • Victory Capital Management reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
  • Victory Capital Management sold 9,122 Tectonic Therapeutic shares in Q3 2021, an estimated $973K.
  • Victory Capital Management first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 13 quarters.
  • Victory Capital Management's Tectonic Therapeutic position peaked at $13.5M in Q1 2020.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.